Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV vaccination to prevent progression of cervical lesions in women with abnormal Pap tests
IRCT20190603043801N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Oct 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of human papillomavirus vaccine in cervical intraepithelial neoplasia (CIN) and Cervical Cancer (CC) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Prevention of progression of cervical lesion. Started Oct 2011; status: completed.
02
Drugs
human papillomavirus vaccine
03
Conditions
cervical intraepithelial neoplasia (CIN)Cervical Cancer (CC)
Beyond the preview
Go deeper on IRCT20190603043801N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190603043801N1.